Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Angelin

Showing results (231-240 of 262) with videos related to

Pageof 27
Sort By:
Journal of Internal Medicine|July 13, 2013
Influence of growth hormone on circulating fibroblast growth factor 21 levels in humansJ Lundberg, C Höybye, T Krusenstjerna-Hafstrøm, et al.
Journal of Internal Medicine|May 28, 2022
Nutrition and stem cell integrity in agingP J Stover, M S Field, H N Brawley, et al.
Atherosclerosis|December 12, 1997
Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS)C Held, P Hjemdahl, N Rehnqvist, et al.
The New England Journal of Medicine|July 26, 1990
Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterolE Reihnér, M Rudling, D Ståhlberg, et al.
Fortschritte Der Medizin|March 20, 1991
[Effect of pravastatin on hepatic cholesterol metabolism]E Reihnér, M Rudling, D Ståhlberg, et al.
Journal of Internal Medicine|February 1, 1993
Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapyL Berglund, O Wiklund, G Eggertsen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2001
Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemiaM W Love, A L Craddock, B Angelin, et al.
Journal of Internal Medicine|July 3, 2018
Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolismA Al-Khaifi, S Straniero, V Voronova, et al.
Journal of Lipid Research|May 1, 1999
VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptorL Nilsson, M Gåfvels, L Musakka, et al.
Clinical Pharmacology and Therapeutics|March 1, 1991
Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humansA Hedman, B Angelin, A Arvidsson, et al.
Pageof 27

Showing results (231-240 of 262) with videos related to

Sort By:
Pageof 27
Journal of Internal Medicine|July 13, 2013
Influence of growth hormone on circulating fibroblast growth factor 21 levels in humansJ Lundberg, C Höybye, T Krusenstjerna-Hafstrøm, et al.
Journal of Internal Medicine|May 28, 2022
Nutrition and stem cell integrity in agingP J Stover, M S Field, H N Brawley, et al.
Atherosclerosis|December 12, 1997
Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS)C Held, P Hjemdahl, N Rehnqvist, et al.
The New England Journal of Medicine|July 26, 1990
Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterolE Reihnér, M Rudling, D Ståhlberg, et al.
Fortschritte Der Medizin|March 20, 1991
[Effect of pravastatin on hepatic cholesterol metabolism]E Reihnér, M Rudling, D Ståhlberg, et al.
Journal of Internal Medicine|February 1, 1993
Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapyL Berglund, O Wiklund, G Eggertsen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2001
Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemiaM W Love, A L Craddock, B Angelin, et al.
Journal of Internal Medicine|July 3, 2018
Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolismA Al-Khaifi, S Straniero, V Voronova, et al.
Journal of Lipid Research|May 1, 1999
VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptorL Nilsson, M Gåfvels, L Musakka, et al.
Clinical Pharmacology and Therapeutics|March 1, 1991
Digoxin-verapamil interaction: reduction of biliary but not renal digoxin clearance in humansA Hedman, B Angelin, A Arvidsson, et al.
Pageof 27